Murakami, Yasuko <br/><br/>
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.  [electronic resource] 

 -  Journal of nutritional science and vitaminology  Jun 2007 
 - 213-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0301-4800 
<br/><br/><label>Standard No.: </label>10.3177/jnsv.53.213  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--blood<br/>Antiviral Agents--therapeutic use<br/>Ascorbic Acid--administration & dosage<br/>Carnosine--administration & dosage<br/>Dietary Supplements<br/>Drug Therapy, Combination<br/>Fatty Acids, Unsaturated--metabolism<br/>Female<br/>Flow Cytometry<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Organometallic Compounds--administration & dosage<br/>Polyethylene Glycols<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>Thiobarbituric Acid Reactive Substances--metabolism<br/>Time Factors<br/>Transaminases--blood<br/>Treatment Outcome<br/>Vitamin E--administration & dosage<br/>Vitamins--administration & dosage<br/>Zinc--administration & dosage<br/>Zinc Compounds--administration & dosage